Equillium Inc (NASDAQ: EQ) kicked off on Monday, down -10.10% from the previous trading day, before settling in for the closing price of $0.86. Over the past 52 weeks, EQ has traded in a range of $0.49-$3.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 32.24% over the past five years. While this was happening, its average annual earnings per share was recorded 1.32%. With a float of $17.42 million, this company’s outstanding shares have now reached $35.42 million.
Let’s look at the performance matrix of the company that is accounted for 44 employees. In terms of profitability, gross margin is 99.78%, operating margin of -14.74%, and the pretax margin is -10.02%.
Equillium Inc (EQ) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Equillium Inc is 50.82%, while institutional ownership is 5.31%. The most recent insider transaction that took place on Jan 23 ’25, was worth 6,500. In this transaction Chief Financial Officer of this company sold 10,000 shares at a rate of $0.65, taking the stock ownership to the 37,720 shares. Before that another transaction happened on Nov 14 ’24, when Company’s Chief Financial Officer sold 10,000 for $0.70, making the entire transaction worth $7,000. This insider now owns 47,720 shares in total.
Equillium Inc (EQ) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.32% per share during the next fiscal year.
Equillium Inc (NASDAQ: EQ) Trading Performance Indicators
Take a look at Equillium Inc’s (EQ) current performance indicators. Last quarter, stock had a quick ratio of 3.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -0.86 in one year’s time.
Technical Analysis of Equillium Inc (EQ)
Equillium Inc (NASDAQ: EQ) saw its 5-day average volume 8.27 million, a positive change from its year-to-date volume of 1.72 million. As of the previous 9 days, the stock’s Stochastic %D was 56.37%. Additionally, its Average True Range was 0.09.
During the past 100 days, Equillium Inc’s (EQ) raw stochastic average was set at 27.51%, which indicates a significant decrease from 38.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 142.74% in the past 14 days, which was higher than the 122.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7017, while its 200-day Moving Average is $0.9109. Nevertheless, the first resistance level for the watch stands at $0.8417 in the near term. At $0.9135, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9569. If the price goes on to break the first support level at $0.7265, it is likely to go to the next support level at $0.6831. The third support level lies at $0.6113 if the price breaches the second support level.
Equillium Inc (NASDAQ: EQ) Key Stats
The company with the Market Capitalisation of 27.28 million has total of 35,431K Shares Outstanding. Its annual sales at the moment are 36,080 K in contrast with the sum of -13,340 K annual income. Company’s last quarter sales were recorded 12,160 K and last quarter income was -10 K.
